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Summary
Aim: The aim of the study was to determine whether certain cognitive domains exist in the assess-
ment of cognitive functions in HD patients, patients with hypothyroidism and HD patients with 
concomitant hypothyroidism.
Material and methods: The patients were divided into 3 groups according to nosology: Group I – 21 
patients with hypertensive disease (HD); Group II – 18 patients with hypothyroidism, Group III – 19 
hypertensive patients with concomitant hypothyroidism.
Results: It was revealed that patients with HD had a decrease in memory according to the test 
proposed by A. R. Luria for learning 10 words, (p<0.05), as well as Digit span from Mattisse scale, 
(p<0.05). In patients with hypothyroidism, a short span of attention was revealed, according to 
the method of «Selectivity of attention» (G. Munsterberg test), (p<0.05). The analysis of the results 
showed that considering the interaction of factors (HD and hypothyroidism), the most affected 
cognitive domains are memory, executive functions and optical- spatial functions, respectively, 
(p<0.05).
Conclusions: To diagnose CI in patients with HD who have problems with the domain of cognitive 
function memory, it is advisable to use a test for learning 10 words according to the method pro-
posed by A. R. Luria and Digit span from Mattisse scale. In patients with hypothyroidism, attention 
and executive functions should be determined using the Schulte Tables and the «Selectivity of At-
tention» method (G. Munsterberg test). With the combined pathology, HD patients with a concomi-
tant hypothyroidism should use Schulte Tables, test for learning 10 words by A. R. Luria and Clock 
Drawing Test.
Key words: cognitive functions, hypertensive disease, hypothyroidism, neuropsychological 
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Summary: The level of cognitive- mnestic functions 
of 58 individuals aged 49.84±0.83 years was studied. The 
patients were divided into 3 groups according to nosolo-
gy: Group I – 21 patients with hypertensive disease (HD); 
Group II – 18 patients with hypothyroidism, Group III – 
19 hypertensive patients with concomitant hypothyroid-
ism. The duration of the disease is 13.56±0.79 years. The 
control group (CG) involved 18 apparently healthy in-
dividuals (AHI) of appropriate age (47.84±0.36 years), 
whose selection was carried out with the consideration of 
the anamnesis, in the absence of hypothyroidism and HD.
At the time of examination, TSH in patients of 
Group II was 3.16±0.79 mIU/liter, (p<0.05), the stage of 
compensation was diagnosed in 83.3%, the stage of sub-
compensation – in 16.7%; in Group III TSH was 2.92±0.78 
mIU/liter, (p <0.05), the stage of compensation of hypo-
thyroidism was diagnosed in 85.7%, the stage of subcom-
pensation – in 14.3%. In 84.7% of cases, hypothyroidism 
was compensated, which was confirmed by the absence 
of clinical symptoms, as well as normal TSH in serum. In 
15.3% of cases, patients did not receive adequate replace-
ment therapy and were subcompensated. After retrospec-
tive analysis of medical records, it was found that their 
levels of TSH were 7.14±2.37 mIU/l and 8.03±6.77 mI-
U/l, respectively, which corresponded to the stage of de-
compensation. The average level of office blood pressure 
(SBP/DBP) in Groups I, III in comparison with CG at 
the time of examination was SBP 134.26±5.23 mm Hg, 
(p<0.05); DBP 84.37± .51 mm Hg, (p<0.05) Group I; SBP 
145.52±5.45 mm Hg, (p<0.05); DBP 82.41±3.86 mm Hg 
(p<0.05) Group III. Retrospective analysis of medical re-
cords revealed insufficient blood pressure control in the 
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relevant groups, the average level of SBP/DBP in Groups I 
and III was 154.38±5.11, (p<0.05)\96.47±3.49 0.05) mm 
Hg; 158.26±5.64, (p<0.05)\98.42±4.93, (p<0.05) mm 
Hg, respectively. To simplify the diagnosis of cognitive- 
mnestic disorders for all groups, the following psychomet-
ric methods were used: «Learning 10 words» – the meth-
od of A. R. Luria, Schulte Tables, Clock Drawing Test, 
Digit span from Mattisse scale and «Selectivity of atten-
tion» (G. Munsterberg test). It was revealed that patients 
with HD had a decrease in memory according to the test 
proposed by A. R. Luria for learning 10 words, (p<0.05), 
as well as Digit span from Mattisse scale, (p<0.05). In 
patients with hypothyroidism, a short span of attention 
was revealed, according to the method of «Selectivity of 
attention» (G. Munsterberg test), (p<0.05). The analy-
sis of the results showed that considering the interaction 
of factors (HD and hypothyroidism), the most affected 
cognitive domains are memory, executive functions and 
optical- spatial functions, respectively, (p<0.05). It should 
be noted that in patients of Group II there is an increase 
in the time of Schulte Tables completion, in comparison 
with Group I, (p<0.05). In addition, there was an increase 
in time spent for words searching, the number of errors 
and omissions in finding and underlining words by the 
method of «Selectivity of attention». The results of the 
study revealed a significant decrease in memory, (p<0.05), 
the presence of moderate cognitive impairment (CI) in 
patients of Group III compared with Group I, (p<0.05). 
Thus, in HD patients with concomitant hypothyroid-
ism, a significant slow processing speed and executive 
function disorders were found, as well as memory loss, 
impaired optical- spatial functions, in comparison with 
Group II, (p<0.05).
Conclusions. To diagnose CI in patients with HD 
who have problems with the domain of cognitive func-
tion memory, it is advisable to use a test for learning 10 
words according to the method proposed by A. R. Luria 
and Digit span from Mattisse scale. In patients with hy-
pothyroidism, attention and executive functions should 
be determined using the Schulte Tables and the «Selec-
tivity of Attention» method (G. Munsterberg test). With 
the combined pathology, HD patients with a concomitant 
hypothyroidism should use Schulte Tables, test for learn-
ing 10 words by A. R. Luria and Clock Drawing Test. The 
study of cognitive functions in patients with HD and hy-
pothyroidism is appropriate even in the compensation of 
the disease, because, as the study showed, in patients with 
lifelong pathology the level of TSH and blood pressure 
fluctuates, which affects cognitive functions: 3.6% of HD 
patients and 7.2% of patients with hypothyroidism suffer 
from cognitive disorders. In the future, this will make it 
possible to identify patients with CI among the patients 
with HD and hypothyroidism and to treat the disorders.
Key words: cognitive functions, hypertensive disease, 
hypothyroidism, neuropsychological testing.
INTRODUCTION
The issue of early diagnosis of cognitive disorders 
is extremely relevant in modern medicine, especially in 
patients with several diseases that may affect the state of 
cognitive functions, which directly or indirectly adverse-
ly affect blood supply to the brain and/or metabolism, in 
particular hypertension and hypothyroidism. Studies have 
shown that one of the most common pathogenetic factors 
in the formation and development of cognitive impairment 
(CI) is HD, especially its long course which leads to CI of 
varying degrees; cerebrovascular pathology on the back-
ground of HD is one of the main causes of cognitive de-
cline [5]. Studies of Systolic Hypertension in Europe tri-
als, PROGRESS, LIFE, SCOPE, MOSES have shown 
that normalization of blood pressure (BP) significantly 
reduces the risk of developing and progressing of CI [6]. 
However, according to the analysis of studies, there is no 
convincing evidence that a decrease in blood pressure in 
patients with HD without cerebrovascular disease in the 
anamnesis prevents the development of CI [7]. Despite 
the widespread world’s reports about the need to control 
blood pressure, the XVIII European Cardiac Congress in 
Birmingham presented disappointing data on the detec-
tion of HD, the attitude of patients to their condition and 
the quality of health care [12]. It was found that among all 
patients who suffer from HD, only about 50% know they 
are sick. Among those aware, only half receive antihy-
pertensive treatment. And of this half, only one in two is 
treated adequately, which is 12.5% of the cohort of people 
with HD [13]. On the basis of the Kharkiv city polyclin-
ic, a long-term prospective study was conducted with the 
aim to study the course of HD, the adequacy of antihy-
pertensive drugs and complications of HD in patients with 
diseases of the internal organs [1]. The results of the study 
(described in 2010) revealed the presence of polypragma-
tism in the treatment of high blood pressure, frequent use 
of second-line drugs (25.1%), lack of practice of titrating 
doses of antihypertensive drugs to optimal, underestimation 
by doctors of more careful blood pressure control and lack 
of timely dose adjustment of antihypertensive drugs for HD 
patients who take drugs for the treatment of comorbidities 
that can increase blood pressure and as a result – a fairly 
low percentage of achieving the target blood pressure in 
patients (36.6%), i. e. only a third of cases. Among all caus-
es of cognitive impairment, metabolic disorders account 
for about 5%, in particular, thyroid dysfunction with the 
development of hypothyroidism. Moreover, given its du-
ration and severity, the prevalence of CI in this pathology 
varies, according to various authors, from 1.3% to 10.3% 
(Niafar M. et al., 2009; Catherine M. Otto, et al., 2012). 
Some authors [8\9] hold the view that cognitive functions 
are restored by compensating for hypothyroidism, but there 
is another opinion: CI that developed in thyroid hormone 
deficiency is irreversible or partially reversible [9]. Accord-
ing to the results of study of thyroid pathology in Ukraine 
and Poltava region in recent years, the prevalence of hy-
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pothyroidism in 2005-2013 has been studied; it was found 
that doctors underestimate the need for more thorough di-
agnosis and lack of timely dose adjustment [4]. It should be 
noted that prolonged deficiency of thyroid hormones caus-
es cognitive deficits, which leads to disability and reduced 
quality of life of patients. Our previous studies identified 
insufficient control of blood pressure in patients with hy-
pertension and thyroid- stimulating hormone (TSH) in pa-
tients with hypothyroidism. According to the retrospective 
analysis of medical documentation of patients with HD, 
we found insufficient blood pressure control; the average 
level of systolic/diastolic blood pressure (SBP/DBP) was 
159.20±8.36/98.00±8.54; 162.50±6.34/101.04±10.01 mm 
Hg, respectively, for patients with hypertension and HD 
patients with concomitant hypothyroidism. Analyzing TSH 
level, it was found that at the time of examination the pa-
tients were at the stage of compensation (TSH=3.96±1.09 
mIU/l; 4.12±0.78 mIU/l, respectively, for patients with 
hypothyroidism and HD patients with concomitant hypo-
thyroidism). We also assessed TSH levels in patients with 
a confirmed history of hypothyroidism. A retrospective 
analysis of the data was performed and it was found that 
in the examined patients the average level of TSH was in-
sufficiently corrected, TSH=7.14±2.37 mIU/l; 8.03±6.77 
mIU/l, for patients with hypothyroidism, HD patients 
with concomitant hypothyroidism, respectively. Given that 
HD and hypothyroidism are important risk factors for CI, 
moreover, these diseases can be mutually burdensome, it is 
especially important to study cognitive function in people 
with combined pathology to determine whether these two 
pathologies have an additive effect on CI. Thus, based on 
our results, which show that HD patients had a signifi-
cantly lower score in the memory domain, patients with 
hypothyroidism had a significantly lower score in the do-
main of attention and executive functions, and analysis 
of the results showed that taking into account the inter-
action factors (HD and hypothyroidism) it was found that 
40% of the most affected cognitive domains are memory 
and speech, and 60% of patients have impaired executive 
functions, as well as optical- spatial functions, respective-
ly. Based on the results, the following psychometric meth-
ods were used to screen for cognitive- mnestic disorders: 
a test for learning 10 words according to the method pro-
posed by A. R. Luria and Digit span from Mattisse scale 
for patients with HD; for patients with hypothyroidism – 
the method of «Selectivity of attention» (G. Munsterberg 
test), Schulte Tables; for HD patients with concomitant 
hypothyroidism – a test for learning 10 words according 
to the method proposed by A. R. Luria, Schulte Tables 
and Clock Drawing Test. The set of neuropsychological 
techniques should be simple enough to diagnose CI re-
gardless of the medical diagnosis of the test subject, but 
at the same time it should be sensitive to relatively minor 
CI, which in the absence of timely correction can lead to 
more severe disorders with dementia. The aim of the study 
was to determine whether certain cognitive domains exist 
in the assessment of cognitive functions in HD patients, 
patients with hypothyroidism and HD patients with con-
comitant hypothyroidism.
Materials and methods. To achieve the goal, we used 
the results of our published work on the study of neuro-
psychological structure of patients with HD, patients with 
hypothyroidism and HD patients with concomitant hy-
pothyroidism. Retrospective analysis of medical records 
revealed insufficient long-term control of blood pressure 
and TSH, which in the future became the cause of CI in 
this group of patients [14]. A comprehensive clinical and 
neurological examination of 58 patients (27 men and 31 
women), mean age – 47.84±0.36 years, disease duration – 
13.56±0.79 years was carried out. The CG involved 18 
people representative of age and sex ratio without a his-
tory of HD, hypothyroidism. Patients were divided into 3 
groups by nosology: Group I – 21 patients with HD who 
received antihypertensive therapy; Group II – 18 patients 
with hypothyroidism who received L-thyroxine at a dose 
of 100-150 mg, Group III – 19 HD patients with concom-
itant hypothyroidism who received appropriate treatment. 
Data used to select patients with HD were the following: 
stage of the disease, the degree of increase in blood pres-
sure, disease duration, the level of SBP and DBP. Patients 
with HD received basic therapy (antihypertensive). The 
diagnosis of hypothyroidism was made by an endocrinol-
ogist according to the recommendations of the American 
Association of Clinical Endocrinologists and the American 
Thyroid Association for the Diagnosis and Treatment of 
Hypothyroidism in Adults [10]. Hypothyroidism caused 
by autoimmune thyroiditis was revealed in 9 (50%) indi-
viduals, as a result of thyroid surgery – in 5 (27.7%) pa-
tients, and in 4 (22.3%) individuals hypothyroidism oc-
curred spontaneously. At the time of examination, the 
stage of compensation of hypothyroidism was diagnosed 
in 5 (27.8%) patients, subcompensation – in 13 (72.2%) 
patients. Exclusion criteria: history of traumatic brain inju-
ry and stroke, mental illness, diseases of the blood system, 
cancer, persistent atrial fibrillation, chronic obstructive 
pulmonary disease (respiratory failure of the I-II stages), 
Diabetes mellitus, renal failure and hepatic failure in the 
stage of decompensation. The study was conducted on the 
basis of the Endocrinology and Neurology departments of 
the Ivano- Frankivsk Regional Clinical Hospital, as well as 
on the basis of the Hypertension department of the Ivano- 
Frankivsk Regional Clinical Cardiology Dispensary. All 
patients gave informed consent before enrollment in the 
study. Assessment of patients’ condition was performed 
on the basis of an algorithmic standard thematic map, 
which included sections of clinical and neuropsychologi-
cal testing. General clinical examination included exam-
ination by a physician, endocrinologist, ECG, laborato-
ry tests. Neuropsychological research included: Schulte 
Tables to assess executive functions, the rate of sensorim-
otor responses, the amount of active attention, training 
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status and fatigue of patients, «Learning 10 words» – the 
method of A. R. Luria and digit span from Mattisse scale, 
which allowed to study the processes of memorization, 
preservation and reproduction of information [5]; atten-
tion studies were performed using the «Munsterberg Tech-
nique» [3]. Disorders of spatial functions were most clear-
ly manifested when performing Clock Drawing Test [3]. 
Statistical processing of the obtained data was performed 
using the statistical data analysis package Statistica 6.0. 
The non-parametric Kolmogorov- Smirnov criterion was 
used to assess the statistical significance of the difference 
between the groups. Changes in indicators under p<0.05 
were considered probable.
Results of research and discussion. The main com-
plaints of patients during the examination were the fol-
lowing: «I cannot remember new information», «I can’t 
do mental arithmetic», «I lose my mind», «I don’t listen 
after 10 minutes of conversation», «It’s hard to concen-
trate», «I think slowly», «Brain fog», «I can’t perform sev-
eral tasks simultaneously», «I have lost confidence in the 
right choice», «I postpone decisions» (Table I). A decrease 
in memory, impaired attention and psychomotor slowing 
were registered in Group III.
Table 1












«I cannot remember new information» 11.11±7.41 14.29±7.64 44.44±11.71*• 57.89±11.33×
« I can’t do mental arithmetic « 5.56±5.40 19.05±8.57 22.22±9.80 31.58±10.66
Attention
«I lose my mind» 16.7±8.78 14.29±7.64 33.33±11.11 42.11±11.33×
« I don’t listen after 10 minutes of 
conversation «
5.56±5.40 14.29±7.64 44.44±11.71*• 36.84±11.07
«Psychomotor speed»
«It’s hard to concentrate» 11.11±7.41 9.52±6.41 44.44±11.71*• 52.63±11.45×
«I think slowly» 11.11±7.41 9.52±6.41 61.11±11.49*• 68.42±10.66×
«Brain fog» 0.00 9.52±6.41 50.00±11.79*• 52.63±11.45×
Executive functions
«I can’t perform several tasks 
simultaneously»
11.11±7.41 19.05±8.57 27.78±10.56 31.58±10.66
«I’ve lost confidence in the right choice» 11.11±7.41 9.52±6.41 27.78±10.56 26,32±10.66
«I postpone decisions» 11.11±7.41 9.52±6.41 27.78±10.56 26.32±10.66
Notes:* reliability of the difference between the data compared to CG, (p<0.05);
• reliability of the difference between the data of Groups I and II, (p<0.05);
× reliability of the difference between the data of Groups I and III, (p<0.05).
A detailed neuropsychological examination was per-
formed, which makes it possible to compare cognitive func-
tions according to individual domains (Table II).
Having selected batteries of tests for rapid assess-
ment of cognitive functions with the consideration of 
the specific clinical situation, we have registered in HD 
patients a decrease in memory according to the test for 
learning 10 words according to the method proposed by 
A. R. Luria (p<0.05), as well as Digit span from Mattisse 
scale (p<0.05). In patients with hypothyroidism, according 
to the method of «Selectivity of attention» (G. Munster-
berg test), a short span of attention was noted (p<0.05). 
For an extended assessment, Schulte Tables were chosen, 
the result of which demonstrates the state ofthe domain 
of the patient’s executive functions and proves a short 
span of attention.
Taking into account the interaction of factors 
(HD and hypothyroidism) the analysis of results showed 
that the most affected cognitive domains are memory, ex-
ecutive functions and optical- spatial functions, respectively 
(p<0.05). Analyzing the data, it should be noted that pa-
tients of Group II spent more time for searching words, 
they made more errors and omissions while searching and 
underlining words according to the method of «Selectiv-
ity of attention» in comparison with Group I (p<0.05). 
In addition, they spent more time filling Schulte Tables, 
which also confirms a short span of attention and instabil-
ity of executive functions. The results of studies revealed 
moderate CI in patients of Group III in comparison with 
Group I (p<0.05). Thus, patients with a combination of 
HD and hypothyroidism showed a significant decrease 
in memory, executive functions, impaired optical- spatial 
functions in comparison with Group II (p<0.05).
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Table II
Indicators of cognitive functions according to neuropsychological testing
Control Group, 
n=12 I, n=21 II, n=18 III, n=19
Memory 1)
Luria’s Test-1, words 9 [9; 10] 7 [5; 8] * 9 [8; 10] 6 [5; 7] *\**\***
Luria’s Test-6, words 8 [7; 9] 8 [7; 10] 8 [7; 9] 4 [3; 6] *\**\***
2) Digit span from Mattisse scale 17 [16; 17] 13[12; 15] * 16 [14; 17] 15 [13; 17] *\**\***
Attention
Method «Selectivity of attention», points 14 [12; 16] 11 [9; 13]* 7 [5; 9] *\** 7 [4; 9] *\**\***
Executive functions / Schulte Tables /
-work efficiency, sec 39 [33; 44] 40 [39; 41] 65 [53; 78]*\** 72 [59; 86] *\**\***
Optical- spatial functions
Clock Drawing Test 9 [9; 10] 9 [9; 10] 9 [8; 9] 8 [7; 9] *\**\***
Notes: * reliability of the difference between the data compared to CG (p<0.05);
** reliability of the difference between the data compared to Group I (p<0,05);
*** reliability of the difference between the data compared to Group II (p<0.05).
Therefore, all patients, according to neuro psycho-
logical testing, had a decrease in cognitive functions, but 
the most pronounced disorders were observed in patients 
with a combination of HD and hypothyroidism. Test-
ing analysis showed that these patients had a decrease in 
memory, executive functions and impaired optical- spatial 
functions. The obtained data are consistent with the re-
sults of similar studies. For example, according to Yakov-
lev O. O. (2013), hypertensive patients with stage II have 
a decrease in short-term memory with a relative preser-
vation of a long-term one. However, there are other data 
in the literature: in many cases the decrease in concen-
tration, memory impairment, as well as increased fatigue 
are observed [11]. There are controversial data on the de-
velopment of CI in subclinical hypothyroidism. It should 
be noted that CI in patients with hypothyroidism is char-
acterized primarily by slowed thinking and processing of 
information – bradyphrenia: the patient needs more than 
normal time and effort to solve intellectual tasks. Many 
studies have found a positive association of cognitive de-
cline in subclinical hypothyroidism (Jensovsky J., et al., 
2002; Boxtel M. P., et al., 2004). Regarding the denial of 
such a correlation, a number of authors argue that sub-
clinical hypothyroidism does not cause global cognitive 
dysfunction. But in specific cognitive domains (memo-
ry and executive functions) there may be a slight deficit.
Patients with subclinical hypothyroidism and sig-
nificant cognitive dysfunction may have independent di-
agnoses that should be evaluated and treated separately 
(Samuels M. H., 2010; Roberts R. O., 2014; Kim J. M., 
2010; Kramer C. K., et al., 2009). It is known that a long-
term combination of HD with concomitant hypothyroid-
ism leads to varying degrees of CI [11] and is a common 
pathogenetic factor in the development of dementia. The 
relevance of the study of this problem is also justified by 
the fact that today there are no clear criteria for the diag-
nosis of CI in the combination of HD with concomitant 
hypothyroidism. This comparative analysis of conven-
tional scales for determining CI can be used in planning 
a diagnostic search to ensure early effective verification of 
changes in cognitive- mnestic functions.
CONCLUSIONS
1. To diagnose CI in hypertensive patients who have 
cognitive function memory loss, it is advisable to use «10 
words learning test» according to A. R. Luria and Digit 
span from Mattisse scale. In patients with hypothyroidism, 
attention and executive functions should be determined 
using the method of «Selectivity of attention» (G. Mun-
sterberg test) and Schulte Tables. Hypertensive patients 
with a concomitant hypothyroidism should undergo «10 
words» method of A. R. Luria, Schulte Tables and Clock 
Drawing Test.
2. The study proved that patients, who suffer from the 
mentioned disorders for a long time, have unstable levels 
of TSH and blood pressure, which affects cognitive func-
tion: 3.6% of hypertensive patients and 7.2% of patients 
with hypothyroidism have cognitive disorders. In the fu-
ture, this will make it possible to identify patients with CI 
among patients with HD and hypothyroidism and to treat 
the disorders. Therefore, the results of the research prove 
that the choice of neuropsychological techniques should be 
made with the consideration of the specific clinical situa-
tion. This comparative analysis of generally accepted scales 
for determining CI can be used in planning a diagnostic 
search to ensure early effective verification of changes in 
intellectual and mnestic functions. All this necessitates the 
use in practice of simple and reliable psychometric tools 
for early diagnosis of cognitive disorders.
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